InvestorsHub Logo
Followers 17
Posts 1527
Boards Moderated 0
Alias Born 05/19/2004

Re: Kenswift post# 462

Monday, 10/24/2011 10:28:22 PM

Monday, October 24, 2011 10:28:22 PM

Post# of 821
Close to 10 years ago, when Serono, in an effort to get a bigger piece of the pediatric growth hormone market, teamed up with Bioject to offer a needle-free option, the combination of the injection technology and the injectable had to be approved by the FDA despite the fact that the injection technology AND the HGH were both approved. (Serono's market share went from something like 6% to 20% within 2-3 years). This is and has been an ongoing issue for Bioject. They have approved technology for delivery of injectables but, the FDA in their infinite wisdom, seem to be saying that every application has to be approved when it is used with Bioject's (approved) solution.

Things that make one go hmmmmm.



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.